Vivos Acquisitions, LLC v. Health Care Resource Network, LLC

CourtDistrict Court, E.D. Virginia
DecidedJanuary 5, 2023
Docket1:19-cv-01606
StatusUnknown

This text of Vivos Acquisitions, LLC v. Health Care Resource Network, LLC (Vivos Acquisitions, LLC v. Health Care Resource Network, LLC) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vivos Acquisitions, LLC v. Health Care Resource Network, LLC, (E.D. Va. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA Alexandria Division

VIVOS ACQUISITIONS, LLC, ) ) Plaintiff, ) ) Civil Action No. 1:19-cv-1606 (RDA/WEF) v. ) ) HEALTH CARE RESOURCE NETWORK, ) LLC, et al., ) ) Defendants. )

MEMORANDUM OPINION AND ORDER

This matter comes before the Court for resolution following a four-day bench trial conducted from November 7, 2022 to November 10, 2022. At issue at the bench trial were the following claims and counterclaims remaining after summary judgment: Plaintiff Vivos Acquisitions, LLC’s (“Vivos” or “Plaintiff”) claim for breach of contract (Count II of the Amended Complaint); and Defendants Health Care Resource Network, LLC (“HCRN”), Laura Bankeroff, and Joann Koutsioukis’ (collectively, “Defendants”) counterclaims for fraud (Count I of the Amended Counterclaim); statutory conspiracy (Count II of the Amended Counterclaim); common law conspiracy (Count III of the Amended Counterclaim); and breach of contract (Count IV of the Amended Counterclaim). The parties also presented evidence on Plaintiff’s breach of fiduciary duty claim against Bankeroff (Count VI of the Amended Complaint) after the Court, on its own motion, decided to reconsider its previous ruling dismissing that claim.1

1 In its April 3, 2020 Memorandum Opinion and Order, this Court dismissed Plaintiff’s breach of fiduciary duty claim against Bankeroff. Dkt. 24. In so doing, this Court reasoned that Maryland law, which governs the Employment Agreement at issue, does not recognize breach of fiduciary duty as an independent tort. Id. at 12-14. However, since this Court issued that Memorandum Opinion and Order, there has been a significant change in the law. Specifically, on July 14, 2020, the Court of Appeals of Maryland held that a breach of fiduciary duty may be Based on all the evidence presented at trial, including the Court’s assessment of the credibility of the witnesses and the weight to be given to each piece of evidence, together with the reasonable inferences drawn from that evidence, the Court enters judgment on Counts II and VI of the Amended Complaint in favor of Defendants and enters judgment on Counts I, II, III, and IV

of the Amended Counterclaim in favor of Plaintiff. In support of this verdict, the Court issues the following findings of fact and conclusions of law pursuant to Federal Rule of Civil Procedure 52(a).2 I. FINDINGS OF FACT Suffice it to say that the circumstances of this matter are beyond convoluted and challenging. However, the factual circumstances of the case are largely undisputed. The significance and interpretation of these facts in light of the dealings between the parties control the disposition of the matter.

Vivos was formed on January 11, 2017 as a Virginia limited liability company with a principal place of business in Prince William County, Virginia. DX 1. Naveen Doki (“N. Doki”) and Silvija Valleru (“Valleru”) were its members. Id. HCRN is a Nevada limited liability company with a principal place of business in Montgomery County, Maryland. DX 3. Prior to February 10, 2017, Laura Bankeroff and Joann Koutsioukis owned 51 and 49 percent, respectively, of its Membership Interests. Trial Tr. 45:13-18.

actionable as an independent cause of action in certain circumstances. Plank v. Cherneski, 469 Md. 548, 559 (2020).

2 Federal Rule of Civil Procedure 52(a) provides in pertinent part: “In an action tried on the facts without a jury . . . the court must find the facts specially and state its conclusions of law separately. The findings and conclusions may be stated on the record after the close of the evidence or may appear in an opinion or a memorandum of decision filed by the court.” Prior to February 2017, Bankeroff and Koutsioukis solicited offers to sell HCRN. During that process, Suresh Venkat Doki (“S. Doki”), Vivos’ director of mergers and acquisitions and N. Doki’s brother, identified himself to them as “Suresh Venkat D.” DX 9; Trial Tr. 561:22-562:2. On February 10, 2022, Bankeroff and Koutsioukis sold their Membership Interests to Vivos for

$8,580,000.00 pursuant to a Membership Interest and Purchase Agreement. PX 1; DX 4; Trial Tr. 91:21-23. The record suggests that what started in this case as a traditional multi-million-dollar purchase of a viable enterprise turned into a multi-tiered leveraged buyout. Just prior to closing it was revealed that of the $8,580,000 purchase price, $4,280,000.00, was to be deferred and paid to Bankeroff and Koutsioukis pursuant to Promissory Notes of $2,182,800.00 and $2,097,200.00. PX 18; Trial Tr. 183:4-187:22. In addition, at closing, HCRN’s existing line of credit balance of $582,942.71 was paid off and subsequently paid to Bankeroff and Koutsioukis in the form of Supplemental Promissory Notes.3 DX 5. The Bankeroff Supplemental Promissory Note was in the amount of $297,300.78, and the Koutsioukis Supplemental Promissory Note was in the amount of $285,641.92. Id. In the documents finalized on the funding date, February 16, 2017, the

Bankeroff Notes added up to $2,480,100.78 and the Koutsioukis Notes added up to $2,382,841.92. DX 11-14. After the sale, Bankeroff remained employed at HCRN. Bankeroff served as the company’s Chief Executive Officer (“CEO”) and President until April 26, 2017, when she became the company’s Administrator. PX 8; Trial Tr. 473:24-25-474:1-20. Vivos secured the Notes by pledging the Membership Interests in HCRN pursuant to a Membership Interest Pledge Agreement. PX 5; DX 15. Vivos, the “Pledgor,” pledged its “Membership Interests purchased to [Bankeroff and Koutsioukis, the] Pledgees[,] as security for

3 The Promissory Notes and the Supplemental Promissory Notes will be referred to collectively as “the Notes.” payment of the Seller Notes . . . .” PX 5; DX 15. Among other restrictions, the Membership Interest Pledge Agreement prohibited Vivos from “sell[ing], assign[ing], hypothecat[ing], convey[ing] or otherwise dispos[ing] of any Pledged Interests or interest therein, or create[ing] a lien, pledge or any encumbrance whatsoever upon the Pledged Interests or its proceeds.” PX 5;

DX 15. The Membership Interest Pledge Agreement also provided that “[t]he parties . . . shall pay their own costs, fees and expenses . . . , and no such costs, fees or expenses shall be paid by or transferred to the Company following Closing.” PX 5; DX 15. Vivos funded the transaction with $3,452,627.00 borrowed from the factoring company Advance Business Capital, LLC d/b/a Triumph Business Capital (“Triumph”). PX 28, 55, 59, 99; Trial Tr. 184:17-20. Vivos did so by using HCRN’s accounts receivable as security for the money, plus $700,000.00 from a “Vivos Acquisitions Loan” and $183,873.00 from HCRN’s own operating accounts at SunTrust Bank. DX 6, 20; Trial Tr. 22:24, 186:4-6. Vivos had borrowed $500,000.00 of the $700,000.00 “Vivos Acquisitions Loan” from Srinivasa R. Kalidindi, a friend of S. Doki’s. Trial Tr. 678:14-18. Through Valleru, Vivos executed a Note dated February 10,

2017—the day of the closing of the HCRN transaction—and granted Kalidindi a 5.88% profits interest in HCRN. DX 7-8; Trial Tr. 620:7-15. Shortly afterwards, on February 20, 2017, Vivos sent HCRN an invoice for $171,600.00 for closing costs stemming from the HCRN transaction. Trial Tr. 623:2-4. Vivos sent this invoice in the name of Federal Systems LLC, and S. Doki told HCRN’s CFO Erin Duffy that the invoice was for “his broker fee for the sale.” Trial Tr. 721:3-5. S. Doki also wrote in an email: “We expect all fees to come out of the parent company. As you very well know, we dont [sic] have funds at Lionshead or Vivos to cover for closing costs.” DX 10.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

College Point Boat Corp. v. United States
267 U.S. 12 (Supreme Court, 1925)
Filak v. George
594 S.E.2d 610 (Supreme Court of Virginia, 2004)
Norris v. Mitchell
495 S.E.2d 809 (Supreme Court of Virginia, 1998)
Horton v. Horton
487 S.E.2d 200 (Supreme Court of Virginia, 1997)
Doswell Ltd. Partnership v. Virginia Electric & Power Co.
468 S.E.2d 84 (Supreme Court of Virginia, 1996)
Ewing v. Ewing
461 S.E.2d 417 (Court of Appeals of Virginia, 1995)
Thompson v. Bacon
425 S.E.2d 512 (Supreme Court of Virginia, 1993)
Froelich v. Erickson
96 F. Supp. 2d 507 (D. Maryland, 2000)
Plank v. Cherneski
231 A.3d 436 (Court of Appeals of Maryland, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
Vivos Acquisitions, LLC v. Health Care Resource Network, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vivos-acquisitions-llc-v-health-care-resource-network-llc-vaed-2023.